Advanced search
Publication Cover
OncoTargets and Therapy Volume 11, 2018 - Issue
Submit an article Journal homepage
120
Views
50
CrossRef citations to date
0
Altmetric
Original Research

Long noncoding RNA H19 mediated the chemosensitivity of breast cancer cells via Wnt pathway and EMT process

Hongli Gao1 Department of Oncology, The Fourth People’s Hospital of Jinan, Jinan, Shandong 250031, People’s Republic of China
,
Guijun Hao1 Department of Oncology, The Fourth People’s Hospital of Jinan, Jinan, Shandong 250031, People’s Republic of China
,
Yue Sun2 Department of Internal Medicine, [email protected]
,
Liye Li3 Department of Surgery (Breast Surgery), Affiliated Hospital of Shandong Academy of Medical Sciences, Jinan, Shandong 250031, People’s Republic of China
&
Yukun Wang2 Department of Internal Medicine, [email protected]Correspondence[email protected]
Pages 8001-8012 | Published online: 09 Nov 2018

Citations (50)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Guobin Zhong, Yuansheng Lin, Xu Wang, Keqiong Wang, Jianlun Liu & Wei Wei. (2020) H19 Knockdown Suppresses Proliferation and Induces Apoptosis by Regulating miR-130a-3p/SATB1 in Breast Cancer Cells. OncoTargets and Therapy 13, pages 12501-12513.
Read now
Tonghua Du, Ying Shi, Shengnan Xu, Xiaoyu Wan, Haiyin Sun & Bin Liu. (2020) Long Non-Coding RNAs in Drug Resistance of Breast Cancer. OncoTargets and Therapy 13, pages 7075-7087.
Read now
Yongkun Wang, Zhen Wu, Yingxue Li, Zheng Zheng, Jinqiang Yan, Shuyan Tian & Lin Han. (2020) Long Non-Coding RNA H19 Promotes Proliferation, Migration and Invasion and Inhibits Apoptosis of Breast Cancer Cells by Targeting miR-491-5p/ZNF703 Axis. Cancer Management and Research 12, pages 9247-9258.
Read now
Ke-Tao Jin, Ze-Bei Lu, Jie-Qing Lv & Jun-Gang Zhang. (2020) The role of long non-coding RNAs in mediating chemoresistance by modulating autophagy in cancer. RNA Biology 17:12, pages 1727-1740.
Read now

Articles from other publishers (46)

Cristian Arriaga-Canon, Laura Contreras-Espinosa, Sergio Aguilar-Villanueva, Enrique Bargalló-Rocha, José Antonio García-Gordillo, Paula Cabrera-Galeana, Clementina Castro-Hernández, Francisco Jiménez-Trejo & L. A. Herrera. (2023) The Clinical Utility of lncRNAs and Their Application as Molecular Biomarkers in Breast Cancer. International Journal of Molecular Sciences 24:8, pages 7426.
Crossref
Oliver Treeck, Silke Haerteis & Olaf Ortmann. (2023) Non-Coding RNAs Modulating Estrogen Signaling and Response to Endocrine Therapy in Breast Cancer. Cancers 15:6, pages 1632.
Crossref
Mehrdad Hashemi, Sahar Hasani, Shima Hajimazdarany, Fatemeh Ghadyani, Yeganeh Olyaee, Marzieh Khodadadi, Maryam Fallah Ziyarani, Amir Dehghanpour, Hasti Salehi, Amirabbas Kakavand, Mohammad Ali Sheikh Beig Goharrizi, Amir Reza Aref, Shokooh Salimimoghadam, Mohammad Esmaeil Akbari, Afshin Taheriazam, Kiavash Hushmandi & Maliheh Entezari. (2023) Biological functions and molecular interactions of Wnt/β-catenin in breast cancer: Revisiting signaling networks. International Journal of Biological Macromolecules 232, pages 123377.
Crossref
Nadine Wehida, Wafaa Abdel-Rehim, Hazem El Mansy, Ahmed Karmouty & Maher A. Kamel. (2023) A Panel of Circulating Non-Coding RNAs in the Diagnosis and Monitoring of Therapy in Egyptian Patients with Breast Cancer. Biomedicines 11:2, pages 563.
Crossref
Kyoko Oura, Asahiro Morishita, Sae Hamaya, Koji Fujita & Tsutomu Masaki. (2023) The Roles of Epigenetic Regulation and the Tumor Microenvironment in the Mechanism of Resistance to Systemic Therapy in Hepatocellular Carcinoma. International Journal of Molecular Sciences 24:3, pages 2805.
Crossref
Viola Melone, Annamaria Salvati, Noemi Brusco, Elena Alexandrova, Ylenia D’Agostino, Domenico Palumbo, Luigi Palo, Ilaria Terenzi, Giovanni Nassa, Francesca Rizzo, Giorgio Giurato, Alessandro Weisz & Roberta Tarallo. (2023) Functional Relationships between Long Non-Coding RNAs and Estrogen Receptor Alpha: A New Frontier in Hormone-Responsive Breast Cancer Management. International Journal of Molecular Sciences 24:2, pages 1145.
Crossref
Mehrdad Hashemi, Hamid Zaferani Arani, Sima Orouei, Shayan Fallah, Amin Ghorbani, Maryam Khaledabadi, Amirabbas Kakavand, Alireza Tavakolpournegari, Hamidreza Saebfar, Hajar Heidari, Shokooh Salimimoghadam, Maliheh Entezari, Afshin Taheriazam & Kiavash Hushmandi. (2022) EMT mechanism in breast cancer metastasis and drug resistance: Revisiting molecular interactions and biological functions. Biomedicine & Pharmacotherapy 155, pages 113774.
Crossref
Mehrdad Hashemi, Marzieh Sadat Moosavi, Hedyeh Maghareh Abed, Maryam Dehghani, Masoumeh Aalipour, Elaheh Ali Heydari, Mitra Behroozaghdam, Maliheh Entezari, Shokooh Salimimoghadam, Emine Selda Gunduz, Afshin Taheriazam, Sepideh Mirzaei & Saeed Samarghandian. (2022) Long non-coding RNA (lncRNA) H19 in human cancer: From proliferation and metastasis to therapy. Pharmacological Research 184, pages 106418.
Crossref
Xun Zhang, Mingpeng Luo, Jiahang Zhang, Bize Guo, Shreya Singh, Xixi Lin, Hanchu Xiong, Siwei Ju, Linbo Wang, Yulu Zhou & Jichun Zhou. (2022) The role of lncRNA H19 in tumorigenesis and drug resistance of human Cancers. Frontiers in Genetics 13.
Crossref
Ahmad Khan & Xiaobo Zhang. (2022) Function of the Long Noncoding RNAs in Hepatocellular Carcinoma: Classification, Molecular Mechanisms, and Significant Therapeutic Potentials. Bioengineering 9:8, pages 406.
Crossref
Zahra Abedi kichi, Mona Soltani, Mina Rezaei, Zeinab Shirvani-Farsani & Mahbubeh Rojhannezhad. (2022) The Emerging Role of EMT-related lncRNAs in Therapy Resistance and their Applications as Biomarkers. Current Medicinal Chemistry 29:26, pages 4574-4601.
Crossref
Carlos Garcia-Padilla, Estefanía Lozano-Velasco, María del Mar Muñoz-Gallardo, Juan Manuel Castillo-Casas, Sheila Caño-Carrillo, Francisco José Martínez-Amaro, Virginio García-López, Amelia Aránega, Diego Franco, Virginio García-Martínez & Carmen López-Sánchez. (2022) LncRNA H19 Impairs Chemo and Radiotherapy in Tumorigenesis. International Journal of Molecular Sciences 23:15, pages 8309.
Crossref
Fariba Nabatchian, Zahra Shafieizadeh, Zohreh Shafieizadeh, Afshin Moradi, Fatemeh Kheiri, Mansoureh Azadeh, Reza Afrisham & Negin Davoudi. (2022) Assessment of Expression of LncRNA H19, Pinin and their Relation to rs532 Single Nucleotide Polymorphism in the Pinin Gene Present in the Tissue of Individuals Suffering from Breast Cancer in Central Iran. Current Cancer Therapy Reviews 18:2, pages 143-147.
Crossref
Pingting Ye, Lei Feng, Shuo Shi & Chunyan Dong. (2022) The Mechanisms of lncRNA-Mediated Multidrug Resistance and the Clinical Application Prospects of lncRNAs in Breast Cancer. Cancers 14:9, pages 2101.
Crossref
Haixiu Yang, Changlu Qi, Boyan Li & Liang Cheng. (2022) Non-coding RNAs as Novel Biomarkers in Cancer Drug Resistance. Current Medicinal Chemistry 29:5, pages 837-848.
Crossref
Yuan-Shan Zhu & Jifeng Zhu. 2022. 91 179 .
Yan Zhang, Denan Zhang, Qingkang Meng, Ziqi Liu, Hongbo Xie, Lei Liu, Fei Xu & Xiujie Chen. (2021) Precision treatment exploration of breast cancer based on heterogeneity analysis of lncRNAs at the single-cell level. BMC Cancer 21:1.
Crossref
Hyun-Wook Lee, Cynthia C. Jose & Suresh Cuddapah. (2021) Epithelial-mesenchymal transition: Insights into nickel-induced lung diseases. Seminars in Cancer Biology 76, pages 99-109.
Crossref
Hong Sun, Guo Wang, Jiaqin Cai, Xiaoxia Wei, Ying Zeng, Yan Peng & Jie Zhuang. (2021) Long non‑coding RNA H19 mediates N‑acetyltransferase 1 gene methylation in the development of tamoxifen resistance in breast cancer. Experimental and Therapeutic Medicine 23:1.
Crossref
Jiaying He, Shaomi Zhu, Xin Liang, Qinxiu Zhang, Xiaohong Luo, Chi Liu & Linjiang Song. (2021) LncRNA as a multifunctional regulator in cancer multi-drug resistance. Molecular Biology Reports 48:8, pages 1-15.
Crossref
Peng Li, Yuwei Li & Lieting Ma. (2021) Long noncoding RNA highly upregulated in liver cancer promotes the progression of hepatocellular carcinoma and attenuates the chemosensitivity of oxaliplatin by regulating miR‐383‐5p/vesicle‐associated membrane protein‐2 axis. Pharmacology Research & Perspectives 9:4.
Crossref
Jéssica Fernanda Barazetti, Tayana Shultz Jucoski, Tamyres Mingorance Carvalho, Rafaela Nasser Veiga, Ana Flávia Kohler, Jumanah Baig, Hend Al Bizri, Daniela Fiori Gradia, Sylvie Mader & Jaqueline Carvalho de Oliveira. (2021) From Micro to Long: Non-Coding RNAs in Tamoxifen Resistance of Breast Cancer Cells. Cancers 13:15, pages 3688.
Crossref
Soudeh Ghafouri-Fard, Hamed Shoorei, Zahra Bahroudi, Atefe Abak & Mohammad Taheri. (2021) The role of H19 lncRNA in conferring chemoresistance in cancer cells. Biomedicine & Pharmacotherapy 138, pages 111447.
Crossref
Dan Wang, Fengjiao Chen, Tao Zeng, Qingxia Tang, Bing Chen, Ling Chen, Yan Dong & Xiaosong Li. (2021) Comprehensive biological function analysis of lncRNAs in hepatocellular carcinoma. Genes & Diseases 8:2, pages 157-167.
Crossref
Priya Mondal & Syed Musthapa Meeran. (2020) Long non-coding RNAs in breast cancer metastasis. Non-coding RNA Research 5:4, pages 208-218.
Crossref
Arash Poursheikhani, Zahra Bahmanpour, Ehsan Razmara, Ladan Mashouri, Mohammad Taheri, Dorsa Morshedi Rad, Hassan Yousefi, Amirreza Bitaraf & Sadegh Babashah. (2020) Non-coding RNAs underlying chemoresistance in gastric cancer. Cellular Oncology 43:6, pages 961-988.
Crossref
Ravishkumar L. Akshaya, Muthukumar Rohini & Nagarajan Selvamurugan. (2020) Regulation of Breast Cancer Progression by Noncoding RNAs. Current Cancer Drug Targets 20:10, pages 757-767.
Crossref
Hui Zhang, Yuanyuan Wang, Xiaomin Liu & Yanli Li. (2020) Progress of long noncoding RNAs in anti-tumor resistance. Pathology - Research and Practice 216:11, pages 153215.
Crossref
Hongyu Zhu. (2020) Silencing long non-coding RNA H19 combined with paclitaxel inhibits nasopharyngeal carcinoma progression. International Journal of Pediatric Otorhinolaryngology 138, pages 110249.
Crossref
Yang Peng, Dihong Tang, Meng Zhao, Hiroaki Kajiyama, Fumitaka Kikkawa & Yutaka Kondo. (2020) Long non-coding RNA: A recently accentuated molecule in chemoresistance in cancer. Cancer and Metastasis Reviews 39:3, pages 825-835.
Crossref
Daniel Rodrigues de Bastos & Maria A. Nagai. (2020) In silico analyses identify lncRNAs: WDFY3-AS2, BDNF-AS and AFAP1-AS1 as potential prognostic factors for patients with triple-negative breast tumors. PLOS ONE 15:5, pages e0232284.
Crossref
Wenxiao Jiang, Jun Xia, Shangdan Xie, Ruanmin Zou, Shuya Pan, Zhi-wei Wang, Yehuda G. Assaraf & Xueqiong Zhu. (2020) Long non-coding RNAs as a determinant of cancer drug resistance: Towards the overcoming of chemoresistance via modulation of lncRNAs. Drug Resistance Updates 50, pages 100683.
Crossref
Justin M Brown, Marie-Claire D Wasson & Paola Marcato. (2020) The Missing Lnc: The Potential of Targeting Triple-Negative Breast Cancer and Cancer Stem Cells by Inhibiting Long Non-Coding RNAs. Cells 9:3, pages 763.
Crossref
Zhaolin Chen, Tingting Pan, Duochen Jiang, Le Jin, Yadi Geng, Xiaojun Feng, Aizong Shen & Lei Zhang. (2020) The lncRNA-GAS5/miR-221-3p/DKK2 Axis Modulates ABCB1-Mediated Adriamycin Resistance of Breast Cancer via the Wnt/β-Catenin Signaling Pathway. Molecular Therapy - Nucleic Acids 19, pages 1434-1448.
Crossref
Lan Huang, Guohua Liang, Qingyuan Zhang & Wenhui Zhao. (2020) The Role of Long Noncoding RNAs in Antiestrogen Resistance in Breast Cancer: An Overview and Update. Journal of Breast Cancer 23:2, pages 129.
Crossref
Emre Özgür, Ferhat Ferhatoğlu, Fatma Şen, Pinar Saip & Ugur Gezer. (2019) Circulating lncRNA H19 may be a useful marker of response to neoadjuvant chemotherapy in breast cancer. Cancer Biomarkers 27:1, pages 11-17.
Crossref
Ji Wang, Shuduo Xie, Jingjing Yang, Hanchu Xiong, Yunlu Jia, Yulu Zhou, Yongxia Chen, Xiaogang Ying, Cong Chen, Chenyang Ye, Linbo Wang & Jichun Zhou. (2019) The long noncoding RNA H19 promotes tamoxifen resistance in breast cancer via autophagy. Journal of Hematology & Oncology 12:1.
Crossref
Ling Wei, Xingwu Wang, Liyan Lv, Jibing Liu, Huaixin Xing, Yemei Song, Mengyu Xie, Tianshui Lei, Nasha Zhang & Ming Yang. (2019) The emerging role of microRNAs and long noncoding RNAs in drug resistance of hepatocellular carcinoma. Molecular Cancer 18:1.
Crossref
Jia Bao Gao, Ming Nan Zhu & Xiao Liang Zhu. (2019) miRNA‐215‐5p suppresses the aggressiveness of breast cancer cells by targeting Sox9. FEBS Open Bio 9:11, pages 1957-1967.
Crossref
Changyong E, Chunsheng Li, Hang Li & Jinghui Yang. (2019) Silencing of a novel lncRNA LOC105369748 suppresses the progression of hepatocellular carcinoma by sponging miR‐5095 from MBD2. Journal of Cellular Physiology 234:10, pages 18504-18512.
Crossref
Xiqiang Xu & Mengmeng Liu. (2019) miR‐522 stimulates TGF‐β/Smad signaling pathway and promotes osteosarcoma tumorigenesis by targeting PPM1A. Journal of Cellular Biochemistry 120:10, pages 18425-18434.
Crossref
Chi, Wang, Wang, Yu & Yang. (2019) Long Non-Coding RNA in the Pathogenesis of Cancers. Cells 8:9, pages 1015.
Crossref
Yu Wu, Ye Yang & Yin-Sheng Xian. (2019) HCRP1 inhibits cell proliferation and invasion and promotes chemosensitivity in esophageal squamous cell carcinoma. Chemico-Biological Interactions 308, pages 357-363.
Crossref
Hualong Zhang, Bin Zhao, Xiuxia Wang, Fan Zhang & Wenlong Yu. (2019) LINC00511 knockdown enhances paclitaxel cytotoxicity in breast cancer via regulating miR-29c/CDK6 axis. Life Sciences 228, pages 135-144.
Crossref
Gugnoni & Ciarrocchi. (2019) Long Noncoding RNA and Epithelial Mesenchymal Transition in Cancer. International Journal of Molecular Sciences 20:8, pages 1924.
Crossref
Mohd Farhan, Mohammad Aatif, Prasad Dandawate & Aamir Ahmad. 2019. Breast Cancer Metastasis and Drug Resistance. Breast Cancer Metastasis and Drug Resistance 229 241 .

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.